ORFADIN (nitisinone) is used for the treatment of patients with Kidney Cancer

ORFADIN is a 4-hydroxyphenylpyruvate dioxygenase inhibitor indicated for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN (nitisinone) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ORFADIN (nitisinone) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the medicine and its cost price in India.

The order for ORFADIN (nitisinone) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) in patients from all ages, in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN® (nitisinone) capsules, for oral use. ORFADIN® (nitisinone) oral suspension. Initial U.S. Approval: 2002

Generic Name: nitisinone

Capsules: 2 mg, 5 mg, 10 mg, 20 mg. (3)
Oral suspension: 4 mg/mL

Orfadin (nitisinone)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to Orfadin (nitisinone) on the Named Patient Import basis in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | MUMBAI | BENGALURU | KOLKATA | LUCKNOW | JAIPUR | JODHPUR | PUNJAB | CHANDIGARH
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

ORFADIN (nitisinone) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ORFADIN (nitisinone) on prescription and Import License in Patient's Name only.

For overseas patients, ORFADIN (nitisinone) can be made available in Send your enquiry to find ORFADIN (nitisinone) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for ORFADIN (nitisinone).

FDA Approves New Generic for Rare HT-1 Disorder

FDA approves ORFADIN® (nitisinone) Oral Suspension For More Details

Get Access To FDA Approved Drug ORFADIN (nitisinone) capsules

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in certain inherited disorder (hereditary tyrosinemia type 1, also known as HT-1) treatment. Brand Name "ORFADIN (nitisinone) capsules" or Generic Name "nitisinone capsules" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.